Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 3:23 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 481–504 of 2,550 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Neurodevelopmental Disorder Clear all

Conditions: Tourette Syndrome, Chronic Tic Disorder
Interventions: Active Oral Orthotic Treatment, Placebo Oral Orthotic Treatment; Device
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 7 Years to 25 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Post Operative Pain
Interventions: Pain and standard side effect management for PNCA with basal method., Pain and standard side effect management with PNCA without basal, Pain and standard side effect management with IV on an as needed basis method.; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 4 Years to 18 Years
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Attention Deficit Disorder With Hyperactivity, Bipolar Disorder, Mental Disorder Diagnosed in Childhood, Mental Retardation, Schizophrenia
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Not listed
Enrollment: 1,227 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2004
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Autism Spectrum Disorder, Parents, Stress
Interventions: Parent-implemented Early Start Denver Model, Mindfulness Based Stress Reduction; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 12 Months and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Autism
Interventions: L1-79, Placebo; Drug
Lead sponsor: Yamo Pharmaceuticals LLC; Industry
Eligibility: 12 Years to 21 Years · Male only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 2
States / cities: Livingston, New Jersey • Sea Girt, New Jersey

Conditions: Huntington Disease, Chorea
Interventions: atomoxetine, Matching Placebo; Drug
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Encopresis, Autistic Disorder
Interventions: Glycerin Suppository, Bisacodyl suppository, Senna; Drug
Lead sponsor: Emory University; Other
Eligibility: 5 Years to 21 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Autism Spectrum Disorder
Interventions: Standard FA+FCT, Pragmatic FA+FCT; Behavioral
Lead sponsor: Matthew J O'Brien, PhD, BCBA-D; Other
Eligibility: 18 Months to 83 Months
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: ADHD
Interventions: OROS-Methylphenidate (MPH); Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 7 Years to 11 Years
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 2
States / cities: Cincinnati, Ohio • Seattle, Washington

Conditions: Speech Sound Disorders
Interventions: Ultrasound visual feedback; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 8 Years to 50 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Math Learning Disability, Learning Disabilities, Learning Disabilities, Child, Dyscalculia, Child Development
Interventions: Speeded practice training, Arithmetic strategy training; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 6 Years to 12 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: EVO; Device
Lead sponsor: Akili Interactive Labs, Inc.; Industry
Eligibility: 8 Years to 12 Years
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 15
States / cities: Scottsdale, Arizona • Newport Beach, California • Sacramento, California + 9 more

Conditions: Autism Spectrum Disorder, Autism
Interventions: EarliPoint Diagnosis, Clinically Certain Expert Clinician Diagnosis (CC-ECD); Device · Behavioral
Lead sponsor: EarliTec Diagnostics, Inc; Industry
Eligibility: 31 Months to 84 Months
Enrollment: 929 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 9
States / cities: Phoenix, Arizona • Altanta, Georgia • Iowa City, Iowa + 6 more

Conditions: Autism, Autism Spectrum Disorder
Interventions: PLAY Project Intervention for Autism, Special education pre-school; Behavioral
Lead sponsor: Richard Solomon MD, Plc; Other
Eligibility: 3 Years to 5 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Central Auditory Processing Disorder, Autism Spectrum Disorder, Sleep Disturbance
Interventions: Not listed
Lead sponsor: Loma Linda University; Other
Eligibility: 6 Years to 17 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Child Development, Infant Development, Developmental Delay, Language Development
Interventions: Building Capacity for Infant Achievements in Child Care; Behavioral
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 18 Years to 100 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Autism Spectrum Disorder
Interventions: Teams Leadership Institute (TLI), Motivational Enhancement (TIPS for Training), Classroom Pivotal Response Teaching (CPRT), An Individualized Mental Health Intervention for ASD (AIM HI), Team-Enhanced Teams Leadership Institute (TLI); Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 1,206 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2027
U.S. locations: 3
States / cities: Sacramento, California • San Diego, California • Westwood, Los Angeles, California

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Stimulants plus Lovaza, Stimulants plus placebo; Dietary Supplement · Drug
Lead sponsor: Antonios Likourezos; Other
Eligibility: 6 Years to 15 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Autism Spectrum Disorder
Interventions: KF-STRIDE; Behavioral
Lead sponsor: Kessler Foundation; Other
Eligibility: 14 Years to 26 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Self-Injurious Behavior, Problem Behavior, Intellectual Disability, Autism Spectrum Disorder, Restricted Behavior
Interventions: AUTOSIB across time, AUTOSIB diminished reinforcement; Behavioral
Lead sponsor: University of Georgia; Other
Eligibility: 2 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Randolph, Massachusetts

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Methylphenidate Transdermal System; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 25 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature
Interventions: No Intervention; Other
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: 18 Months to 26 Months
Enrollment: 68,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1993 – 2030
U.S. locations: 31
States / cities: Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 26 more

Conditions: Attention-Deficit/Hyperactivity Disorder
Interventions: ABT-089, Placebo; Drug
Lead sponsor: AbbVie (prior sponsor, Abbott); Industry
Eligibility: 18 Years to 60 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 12
States / cities: Lafayette, California • Jacksonville, Florida • Orlando, Florida + 9 more

Conditions: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: SHP465, Placebo; Drug
Lead sponsor: Shire; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 41
States / cities: Dothan, Alabama • Little Rock, Arkansas • Anaheim, California + 36 more

Search by objective public record fields.

Proof of Concept Study of an Oral Orthotic to Reduce Tic Severity in Chronic Tic Disorder and Tourette Syndrome

Parent Nurse Controlled Analgesic in Pediatric Patients With Developmental Delay

Genetic Aspects of Neurologic and Psychiatric Disorders

Mindfulness Training and Parent-coaching Interventions for Autism Spectrum Disorder

Safety of L1-79 in Adolescent and Adult Males With Autism

Atomoxetine and Huntington's Disease

An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders

Comparing Behavioral Assessments Using Telehealth for Children With Autism

The Effects of ADHD Medication (TEAM) Study

Ultrasound Biofeedback for Speech Sound Disorders

Intervention on Mathematical Problem-Solving Skills

Software Treatment for Actively Reducing Severity of ADHD - Follow Up

Dynamic Quantification of Social-Visual Engagement in Autism Spectrum Disorder (ASD)

Randomized Controlled Trial of the P.L.A.Y. (Play and Language for Autistic Youngsters) Project Intervention for Autism

Sleep and Central Auditory Processing Disorder in Autism Spectrum Disorder

Expanding the Infant Achievements Intervention Through Community Partnerships

Translating Evidence-based Interventions for ASD: Multi-Level Implementation Strategy

Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD

KF STRIDE to Improve Job Interview Skills

Expanding Interventions for Automatically Maintained SIB

Enhancing ADHD Driving Performance With Stimulant Medication

Follow-up Visit of High Risk Infants

Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years